September is Suicide Prevention Awareness Month: Emergency Resources for Individuals with Perinatal Mental Health Issues
If you or someone you know is in crisis, confidential support is available.
Essential Reads: Why All Women of Reproductive Age Should Take Folic Acid
Folic Acid Awareness Week (Sept 7–14, 2025) focuses on the importance of daily folic acid supplements for women to prevent birth defects, as diet alone is often insufficient.
Breastfeeding and Maternal Mood: Exploring a Complex, Bidirectional Relationship
The relationship between breastfeeding and postpartum depression is complex and bidirectional, with each influencing the other through biological, psychological, and social factors.
Information for Patients: How to Interpret the Recent FDA Panel on SSRIs and Pregnancy
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother.Â
Zuranolone and Breastfeeding: Emerging Data and Clinical Implications
Treatment with zuranolone, a novel oral antidepressant for postpartum depression, raises important questions for breastfeeding individuals. While recent studies show minimal transfer into breast milk, we do not yet have enough information to recommend breastfeeding while taking zuranolone.
Balancing Risks and Benefits: Making Well-Informed Decisions About Medications and BreastfeedingÂ
An individualized, collaborative approach to decision-making helps mothers navigate complex choices with confidence, ensuring the well-being of their child, while attending to their own mental health. Â
You Asked: Can Zuranolone Be Used to Treat Postpartum Depression in a Mother with Bipolar Disorder?
While zuranolone may show promise for the treatment of depressive episodes in patients with bipolar disorder, more research is needed.
Weighing the Evidence: Response to the FDA’s Recent Panel on Antidepressant Use in Pregnancy.
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother.Â
Using AI and Data from the Medical Record to Identify Individuals at Risk for Postpartum Depression
In a recent study from Mass General Hospital, researchers examined whether information included in the medical record at the time of discharge after delivery could help us to identify individuals at increased risk for postpartum depression.
Postpartum Depression with Comorbid Anxiety: Optimizing Treatment
Postpartum anxiety is a common and often under-recognized condition that affects a substantial proportion of new mothers.